This country profile provides an overview of Zimbabwe’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 44/100
Overall rank: Joint 18th

Treatment coverage

Lymphatic filariasis
79%
Onchocerciasis
N/A
Schistosomiasis
93%
STH
75%
Trachoma
7%
7.2 million people received treatment in Zimbabwe in 2016 2.7 million people in need did not receive treatment in Zimbabwe in 2016

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Zimbabwe.

Zimbabwe recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

⬆ Treatment coverage increased from 0% in 2015 to 79% in 2016.

People needing treatment
7.68m
People receiving treatment
6.04m

Onchocerciasis

Zimbabwe does not require mass treatment for onchocerciasis.

Schistosomiasis

⬇ Treatment coverage decreased from 97% in 2015 to 93% in 2016.

School-aged children needing treatment
2.23m
School-aged children receiving treatment
2.08m

Soil-transmitted helminths

⬆ Treatment coverage increased from 42% in 2015 to 75% in 2016.

Pre-sch and school-aged children needing treatment
5.15m
Pre-school and school-aged children receiving treatment
3.84m

Trachoma

⬆ Treatment coverage increased from 0% in 2015 to 7% in 2016.

People needing treatment
1.56m
People receiving treatment
116,000